4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000947871-25-000120
Director bought 550,000 shares at $18.00 ($9,900,000)
- Director acquired 3,154,959 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
ORBIMED ADVISORS LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-10 | Conversion : show line 1 in the form | +3,154,959 | 3,154,959 | I | ||
| 2025-02-10 | Purchase : show line 2 in the form | +550,000 | $18.00 | $9,900,000 | 3,704,959 | I |
| Open-market purchases · 550,000 sh · avg $18.00 · $9,900,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-10 | Conversion : show line 3 in the form Series B convertible preferred stock | −2,560,951 | 0 | I |
| 2025-02-10 | Conversion : show line 4 in the form Series C convertible preferred stock | −2,048,760 | 0 | I |
Loading xslF345X05/ownership.xml…